山东大学耳鼻喉眼学报 ›› 2019, Vol. 33 ›› Issue (1): 25-27.doi: 10.6040/j.issn.1673-3770.1.2018.036

• 专家笔谈 • 上一篇    下一篇

探讨儿童过敏性哮喘的若干问题

邵洁*()   

  1. 上海交通大学医学院附属瑞金医院儿科, 上海 200025
  • 收稿日期:2018-11-08 出版日期:2019-01-20 发布日期:2019-01-28
  • 通讯作者: 邵洁 E-mail:dr.shaojie@163.com
  • 作者简介:邵洁,上海交通大学医学院附属瑞金医院儿科主任医师,儿科学硕士,内科学博士。主要学术任职:中华医学会变态反应学分会第三届、第四届青年委员会副主任委员,中华医学会变态反应学分会第五届委员会委员、副秘书长,中国医师协会儿科医师分会第三届儿童过敏专家委员会委员,中国医疗保健国际交流促进会过敏科学分会常委,上海市医学会儿科专科分会呼吸学组委员。曾赴法国斯特拉斯堡路易-巴斯德大学医院肺和过敏反应科、瑞典南斯德哥尔摩综合医院过敏反应科进修。主要从事儿童哮喘及过敏性鼻炎、过敏性结膜炎、过敏性皮炎、食物过敏等过敏相关性疾病的临床和研究工作

Problems associated with allergic asthma in children

Jie SHAO*()   

  1. Department of Pediatrics, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, China
  • Received:2018-11-08 Online:2019-01-20 Published:2019-01-28
  • Contact: Jie SHAO E-mail:dr.shaojie@163.com

摘要:

全球儿童哮喘发病率为8%~28%,中国儿童哮喘流行病学研究发现,有近1/3哮喘患儿未得到及时和准确诊断。早期预防、长期转归、风险因素,以及生物治疗方法等问题都是儿童哮喘研究关注的问题。

关键词: 儿童, 过敏性哮喘, 早期预防, 表型, 奥马珠单抗

Abstract:

The prevalence of childhood asthma varies from 8%-28% worldwide. Pediatric epidemiological studies in China have found that nearly one-third of the children with asthma have not received appropriate management. More attentions need to be paid to early interventions, treatments, and long-term outcomes of childhood asthma.

Key words: Child, Allergic asthma, Early prevention, Phenotype, Omalizumab

中图分类号: 

  • R256.12
1 Lai CK , Beasley R , Crane J , et al. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC)[J]. Thorax, 2009, 64 (6): 476- 483.
doi: 10.1136/thx.2008.106609
2 Weinmayr G, Jaensch A, Ruelius AK, et al. Can environment or allergy explain international variation in prevalence of wheeze in childhood?[J]. Eur J Epidemiol, 2018, Nov11[Epub ahead of print]. doi:10.1007/s10654-018-0463-z.
3 全国儿童哮喘协作组, 中国疾病预防控制中心环境与健康相关产品安全所. 第三次中国城市儿童哮喘流行病学调查[J]. 中华儿科杂志, 2013, 51 (10): 729- 735.
doi: 10.3760/cma.j.issn.0578-1310.2013.10.003
4 Munblit D , Peroni DG , Boix-Amorós A , et al. Human milk and allergic diseases: an unsolved puzzle[J]. Nutrients, 2017, 9 (8): 894- 896.
doi: 10.3390/nu9080894
5 Kim KS , Hong SW , Han D , et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine[J]. Science, 2016, 351 (6275): 858- 863.
doi: 10.1126/science.aac5560
6 Iordanidou M , Loukides S , Paraskakis E . Asthma phenotypes in children and stratified pharmacological treatment regimens[J]. Exp Rev Clin Pharmacol, 2017, 10 (3): 293- 303.
doi: 10.1080/17512433.2017.1271322
7 Loza MJ , Djukanovic R , Chung KF , et al. Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study[J]. Respir Res, 2016, 17 (1): 165- 169.
doi: 10.1186/s12931-016-0482-9
8 Global initiative for asthma(2016). GINA Report: Global Strategy For Asthma Management and Prevention, 2016[EB/OL]. (2016-08-01) [2018-11-08]. http://www.ginasthma.org.
9 Papadopoulos NG , Arakawa H , Carlsen KH , et al. International consensus on (ICON) pediatric asthma[J]. Allergy, 2012, 67: 976- 997.
doi: 10.1111/j.1398-9995.2012.02865.x
10 Pelaia G , Gallelli L , Renda T , et al. Update on optimal use of omalizumab in management of asthma[J]. J Asthma Allergy, 2011, 4: 49- 59.
doi: 10.2147/JAA.S14520
11 Administration FaD. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103976s521llbl.pdf3.
12 Federal Drug Administration Advisory for Omalizumab[EB/OL]. (2014-07-02)[2018-11-08].http://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/ucm093373.htm.
13 European Medicines Agency[EB/OL]. (2014-07-02)[2018-11-08]. assessment report for Xolair. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000606/human_med_001162.jsp&mid=WC0b01ac058001d124.
[1] 朱希倩,王佳,孙祖贤,冯建秀,张梦佳,赵颖,王宏,姜敏敏. 上海市杨浦区2022—2024年6~9岁学龄儿童屈光状态分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 102-109.
[2] 宋艳玲,司元元,崔彦. 微量玻璃体切除治疗激光笔致儿童全层黄斑裂孔1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 144-147.
[3] 刘南仙,杨泽垠,韩琳,张爱英,赵宇亮,薛静,孙怡君,邵永良. 视频脑电图在儿童复发性眩晕诊断中的意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 20-25.
[4] 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[5] 黄焕,华红利,邓玉琴,江承洋,王雨薇,杨星海. 儿童过敏性鼻炎、扁桃体腺样体肥大和鼻窦炎之间相关性及其对临床指导价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 34-41.
[6] 王华,张丰珍,龙婷,赵靖,李宏彬,王生才,王桂香. 后颅窝肿瘤术后儿童气管切开原因及预后转归分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 168-173.
[7] 乐冰艳,邹剑,雷蕾,文巧,钱应雪. 儿童扁桃体微生物群与免疫调节及疾病关联[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 193-200.
[8] 黄爱萍,王娟,王丽,耿江桥,王亚芳,温鑫. 儿童原发扁桃体Burkitt淋巴瘤累及上颌骨和肺1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 148-152.
[9] 刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[10] 付圣尧,陈敏,庞文会,李娜. 内镜辅助个体化手术入路治疗儿童鼻中线囊肿及瘘管[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 65-71.
[11] 陈丹萍,何子键,虞幼军,周晓娓. 儿童突发性聋10年住院病例的疗效及预后相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 16-22.
[12] 杨娜,柳荫,郭宝,纪尧峰,成晨,张琛,董丽娜. 高频超声在儿童鼻骨骨折闭合复位术的应用研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 41-45.
[13] 王登茂,温鑫,耿江桥,张光远,刘晓峰. 儿童咽鼓管毛息肉合并鼻咽部错构瘤1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 105-109.
[14] 张韵秋,任秀敏,徐鸥,董金辉,王建星. 奥马珠单抗靶向治疗慢性鼻窦炎伴鼻息肉的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 136-140.
[15] 姚婷婷,张德伦,李兰. 婴儿下咽部胃黏膜异位症引发咽喉反流症状1例并文献回顾[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 126-130.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!